Cargando…

A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines

Biomimetic strategies are useful for designing potent vaccines. Decorating a nanoparticulate adjuvant with cell membrane fragments as the antigen‐presenting source exemplifies, such as a promising strategy. For translation, a standardizable, consistent, and scalable approach for coating nanoadjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Hanze, Yang, Chao, Zhang, Fan, Li, Mingqiang, Tu, Zhaoxu, Mu, Lizhong, Dawulieti, Jianati, Lao, Yeh‐Hsing, Xiao, Zixuan, Yan, Huize, Sun, Wen, Shao, Dan, Leong, Kam W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336609/
https://www.ncbi.nlm.nih.gov/pubmed/34386315
http://dx.doi.org/10.1002/advs.202002020
_version_ 1783733353948643328
author Hu, Hanze
Yang, Chao
Zhang, Fan
Li, Mingqiang
Tu, Zhaoxu
Mu, Lizhong
Dawulieti, Jianati
Lao, Yeh‐Hsing
Xiao, Zixuan
Yan, Huize
Sun, Wen
Shao, Dan
Leong, Kam W.
author_facet Hu, Hanze
Yang, Chao
Zhang, Fan
Li, Mingqiang
Tu, Zhaoxu
Mu, Lizhong
Dawulieti, Jianati
Lao, Yeh‐Hsing
Xiao, Zixuan
Yan, Huize
Sun, Wen
Shao, Dan
Leong, Kam W.
author_sort Hu, Hanze
collection PubMed
description Biomimetic strategies are useful for designing potent vaccines. Decorating a nanoparticulate adjuvant with cell membrane fragments as the antigen‐presenting source exemplifies, such as a promising strategy. For translation, a standardizable, consistent, and scalable approach for coating nanoadjuvant with the cell membrane is important. Here a turbulent mixing and self‐assembly method called flash nanocomplexation (FNC) for producing cell membrane‐coated nanovaccines in a scalable manner is demonstrated. The broad applicability of this FNC technique compared with bulk‐sonication by using ten different core materials and multiple cell membrane types is shown. FNC‐produced biomimetic nanoparticles have promising colloidal stability and narrow particle polydispersity, indicating an equal or more homogeneous coating compared to the bulk‐sonication method. The potency of a nanovaccine comprised of B16‐F10 cancer cell membrane decorating mesoporous silica nanoparticles loaded with the adjuvant CpG is then demonstrated. The FNC‐fabricated nanovaccines when combined with anti‐CTLA‐4 show potency in lymph node targeting, DC antigen presentation, and T cell immune activation, leading to prophylactic and therapeutic efficacy in a melanoma mouse model. This study advances the design of a biomimetic nanovaccine enabled by a robust and versatile nanomanufacturing technique.
format Online
Article
Text
id pubmed-8336609
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83366092021-08-11 A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines Hu, Hanze Yang, Chao Zhang, Fan Li, Mingqiang Tu, Zhaoxu Mu, Lizhong Dawulieti, Jianati Lao, Yeh‐Hsing Xiao, Zixuan Yan, Huize Sun, Wen Shao, Dan Leong, Kam W. Adv Sci (Weinh) Communications Biomimetic strategies are useful for designing potent vaccines. Decorating a nanoparticulate adjuvant with cell membrane fragments as the antigen‐presenting source exemplifies, such as a promising strategy. For translation, a standardizable, consistent, and scalable approach for coating nanoadjuvant with the cell membrane is important. Here a turbulent mixing and self‐assembly method called flash nanocomplexation (FNC) for producing cell membrane‐coated nanovaccines in a scalable manner is demonstrated. The broad applicability of this FNC technique compared with bulk‐sonication by using ten different core materials and multiple cell membrane types is shown. FNC‐produced biomimetic nanoparticles have promising colloidal stability and narrow particle polydispersity, indicating an equal or more homogeneous coating compared to the bulk‐sonication method. The potency of a nanovaccine comprised of B16‐F10 cancer cell membrane decorating mesoporous silica nanoparticles loaded with the adjuvant CpG is then demonstrated. The FNC‐fabricated nanovaccines when combined with anti‐CTLA‐4 show potency in lymph node targeting, DC antigen presentation, and T cell immune activation, leading to prophylactic and therapeutic efficacy in a melanoma mouse model. This study advances the design of a biomimetic nanovaccine enabled by a robust and versatile nanomanufacturing technique. John Wiley and Sons Inc. 2021-05-01 /pmc/articles/PMC8336609/ /pubmed/34386315 http://dx.doi.org/10.1002/advs.202002020 Text en © 2021 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Communications
Hu, Hanze
Yang, Chao
Zhang, Fan
Li, Mingqiang
Tu, Zhaoxu
Mu, Lizhong
Dawulieti, Jianati
Lao, Yeh‐Hsing
Xiao, Zixuan
Yan, Huize
Sun, Wen
Shao, Dan
Leong, Kam W.
A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines
title A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines
title_full A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines
title_fullStr A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines
title_full_unstemmed A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines
title_short A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines
title_sort versatile and robust platform for the scalable manufacture of biomimetic nanovaccines
topic Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336609/
https://www.ncbi.nlm.nih.gov/pubmed/34386315
http://dx.doi.org/10.1002/advs.202002020
work_keys_str_mv AT huhanze aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT yangchao aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT zhangfan aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT limingqiang aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT tuzhaoxu aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT mulizhong aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT dawulietijianati aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT laoyehhsing aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT xiaozixuan aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT yanhuize aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT sunwen aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT shaodan aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT leongkamw aversatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT huhanze versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT yangchao versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT zhangfan versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT limingqiang versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT tuzhaoxu versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT mulizhong versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT dawulietijianati versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT laoyehhsing versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT xiaozixuan versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT yanhuize versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT sunwen versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT shaodan versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines
AT leongkamw versatileandrobustplatformforthescalablemanufactureofbiomimeticnanovaccines